The role of the primary care physician in helping adolescent and adult patients improve asthma control

Mayo Clinic Proceedings

Volumn 86, Issue 9, 2011, Pages 894-902

  Yawn, Barbara P ^a  

^a OLMSTED MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN; ANTIASTHMATIC AGENT; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; COLCHICINE; CORTICOSTEROID; CROMOGLYCATE DISODIUM; CYCLOSPORIN; GOLD; IMMUNOGLOBULIN; IMMUNOGLOBULIN E; INTERLEUKIN 4 RECEPTOR; INTERLEUKIN 5 ANTIBODY; LEUKOTRIENE RECEPTOR STIMULATING AGENT; METHOTREXATE; NEDOCROMIL; OMALIZUMAB; RECOMBINANT INTERLEUKIN 12; THEOPHYLLINE; TOBACCO SMOKE; TROLEANDOMYCIN; ZILEUTON;

ADOLESCENT; ADULT; AIR POLLUTION; ASTHMA; ASTHMA APGAR; ASTHMA CONTROL QUESTIONNAIRE; ASTHMA CONTROL TEST; ASTHMA THERAPY ASSESSMENT QUESTIONNAIRE; COCKROACH; CONSULTATION; DANDER; DERMATOPHAGOIDES; DESENSITIZATION; DISEASE CONTROL; DISEASE EXACERBATION; DRUG USE; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL FACTOR; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; GENERAL PRACTITIONER; HUMAN; IMMUNOTHERAPY; INHALER; MEDICAL ASSESSMENT; MEDICAL DECISION MAKING; MEDICAL EXAMINATION; MEDICAL SPECIALIST; MEDLINE; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; OCCUPATIONAL EXPOSURE; PATIENT ATTITUDE; PATIENT COMPLIANCE; PATIENT REFERRAL; PHYSICIAN ATTITUDE; PRACTICE GUIDELINE; REVIEW; SPIROMETRY; SYSTEMATIC REVIEW; UNSPECIFIED SIDE EFFECT;

EID: 80052227803     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.4065/mcp.2011.0035     Document Type: Review

References (47)

1. Sullivan SD, Rasouliyan L, Russo PA, Kamath T, Chipps BE. Extent, patterns, and burden of uncontrolled disease in severe or difficult-to-treat asthma. Allergy. 2007;62(2):126-133. (Pubitemid 46090293)
2. Schmier JK, Manjunath R, Halpern MT, Jones ML, Thompson K, Diette GB. The impact of inadequately controlled asthma in urban children on quality of life and productivity. Ann Allergy Asthma Immunol. 2007;98(3):245-251. (Pubitemid 46420233)
3. Eaton DK, Kann L, Kinchen S, et al; Centers for Disease Control and Prevention (CDC). Youth risk behavior surveillance: United States, 2009. MMWR Surveill Summ. 2010;59(5):1-142.
4. Stanford RH, Gilsenan AW, Ziemiecki R, Zhou X, Lincourt WR, Ortega H. Predictors of uncontrolled asthma in adult and pediatric patients: analysis of the Asthma Control Characteristics and Prevalence Survey Studies (ACCES). J Asthma. 2010;47(3):257-262.
5. Chen H, Gould MK, Blanc PD, et al. Asthma control, severity, and quality of life: quantifying the effect of uncontrolled disease. J Allergy Clin Immunol. 2007;120(2):396-402. (Pubitemid 47103330)
6. Sullivan PW, Ghushchyan VH, Slejko JF, Belozeroff V, Globe DR, Lin SL. The burden of adult asthma in the United States: evidence from the Medical Expenditure Panel Survey. J Allergy Clin Immunol. 2011;127(2):363-369.
7. Barnett SB, Nurmagambetov TA. Costs of asthma in the United States: 2002-2007. J Allergy Clin Immunol. 2011;127(1):145-152.
8. Towns SJ, van Asperen PP. Diagnosis and management of asthma in adolescents. Clin Respir J. 2009;3(2):69-76.
9. DiMatteo MR. Variations in patients' adherence to medical recommendations: a quantitative review of 50 years of research. Med Care. 2004; 42(3):200-209.
10. Buston KM, Wood SF. Non-compliance amongst adolescents with asthma: listening to what they tell us about self-management. Fam Pract. 2000; 17(2):134-138. (Pubitemid 30201055)
11. Edgecombe K, Latter S, Peters S, Roberts G. Health experiences of adolescents with uncontrolled severe asthma. Arch Dis Child. 2010;95(12):985-991.
12. US Department of Health and Human Services (DHS); National Institutes of Health (NIH). National Asthma Education and Prevention Program: Expert Panel Report 3: Guidelines for the Diagnosis and Management of Asthma. Bethesda, MD: National Institutes of Health, National Heart Lung and Blood Institute; 2007. NIH publication No: 97-4051. http://www.ncbi.nlm.nih.gov /books/NBK2358/. Accessed May 12, 2011.
13. Long AA. Addressing unmet needs in asthma care. P&T Digest. 2005;30(11):16-22. http://www.ptcommunity.com/ptdigest/0511-ptd-asthma /PTD-asthma-PT.pdf. Accessed May 12, 2011.
14. Fuchs HJ, Borowitz DS, Christiansen DH, et al; Pulmozyme Study Group. Effect of aerosolized recombinant human DNase on exacerbations of respiratory symptoms and on pulmonary function in patients with cystic fibrosis. N Engl J Med. 1994;331(10):637-642. (Pubitemid 24276863)
15. Holgate ST, Price D, Valovirta E. Asthma out of control? A structured review of recent patient surveys. BMC Pulm Med. 2006;(6)(suppl 1):S2.
16. Janson S, Becker G. Reasons for delay in seeking treatment for acute asthma: the patient's perspective. J Asthma. 1998;35(5):427-435. (Pubitemid 28438362)
17. Mintz M, Gilsenan AW, Bui CL, et al. Assessment of asthma control in primary care. Curr Med Res Opin. 2009;25(10):2523-2531.
18. Walter MJ, Castro M, Kunselman SJ, et al. Predicting worsening asthma control following the common cold. Eur Respir J. 2008;32(6):1548-1554.
19. Carlton BG, Lucas DO, Ellis EF, Conboy-Ellis K, Shoheiber O, Stempel DA. The status of asthma control and asthma prescribing practices in the United States: results of a large prospective asthma control survey of primary care practices. J Asthma. 2005;42(7):529-535. (Pubitemid 41765300)
20. Yawn BP, Enright PL, Lemanske RF Jr, et al. Spirometry can be done in family physicians' offices and alters clinical decisions in management of asthma and COPD. Chest. 2007;132(4):1162-1168. (Pubitemid 47620988)
21. Juniper EF, Bousquet J, Abetz L, Bateman ED. Identifying 'well-controlled' and 'not well-controlled' asthma using the Asthma Control Questionnaire. Respir Med. 2006;100(4):616-621.
22. Juniper EF, O'Byrne PM, Ferrie PJ, King DR, Roberts JN. Measuring asthma control: clinic questionnaire or daily diary? Am J Respir Crit Care Med. 2000;162(4, pt 1):1330-1334.
23. H yland ME, Kenyon CA, Allen R, Howarth P. Diary keeping in asthma: comparison of written and electronic methods. BMJ. 1993;306(6876): 487-489.
24. Juniper EF, O'Byrne PM, Guyatt GH, Ferrie PJ, King DR. Development and validation of a questionnaire to measure asthma control. Eur Respir J. 1999;14(4):902-907. (Pubitemid 29519356)
25. Yawn BP, Bertram S, Wollan P. Introduction of Asthma APGAR tools improve asthma management in primary care practices. J Asthma Allergy. 2008;1:1-10.
26. Yawn BP, Brenneman SK, Allen-Ramey FC, Cabana MD, Markson LE. Assessment of asthma severity and asthma control in children. Pediatrics. 2006;118(1):322-329. (Pubitemid 46071178)
27. Liu AH, Zeiger R, Sorkness C, et al. Development and cross-sectional validation of the Childhood Asthma Control Test. J Allergy Clin Immunol. 2007;119(4):817-825. (Pubitemid 46527825)
28. Juniper EF, Gruffydd-Jones K, Ward S, Svensson K. Asthma Control Questionnaire in children: validation, measurement properties, interpretation. Eur Respir J. 2010;36(6):1410-1416.
29. Schatz M, Mosen DM, Kosinski M, et al. Validity of the Asthma Control Test completed at home. Am J Manag Care. 2007;13(12):661-667. (Pubitemid 350294567)
30. Pinnock H, Juniper EF, Sheikh A. Concordance between supervised and postal administration of the Mini Asthma Quality of Life Questionnaire (MiniAQLQ) and Asthma Control Questionnaire (ACQ) was very high. J Clin Epidemiol. 2005;58(8):809-814. (Pubitemid 40966838)
31. Nathan RA, Sorkness CA, Kosinski M, et al. Development of the asthma control test: a survey for assessing asthma control. J Allergy Clin Immunol. 2004;113(1):59-65. (Pubitemid 38096162)
32. Zhou X, Ding FM, Lin JT, et al. Validity of Asthma Control Test in Chinese patients. Chin Med J (Engl). 2007;120(12):1037-1041. (Pubitemid 47180875)
33. Vega JM, Badia X, Badiola C, et al. Validation of the Spanish version of the Asthma Control Test. J Asthma. 2007;44(10):867-872.
34. Vollmer WM, Markson LE, O'Connor E, et al. Association of asthma control with health care utilization and quality of life. Am J Respir Crit Care Med. 1999;160(5, pt 1):1647-1652.
35. Vollmer WM, Markson LE, O'Connor E, Frazier EA, Berger M, Buist AS. Association of asthma control with health care utilization: a prospective evaluation. Am J Respir Crit Care Med. 2002;165(2):195-199. (Pubitemid 34084457)
36. Wallenstein GV, Carranza-Rosenzweig J, Kosinski M, Blaisdell-Gross B, Gajria K, Jhingran P. A psychometric comparison of three patient-based measures of asthma control. Curr Med Res Opin. 2007;23(2):369-377. (Pubitemid 46333385)
37. Cabana MD, Rand CS, Becher OJ, Rubin HR. Reasons for pediatrician nonadherence to asthma guidelines. Arch Pediatr Adolesc Med. 2001; 155(9):1057-1062. (Pubitemid 32824052)
38. Cabana MD. A randomized trial of primary care provider prompting to enhance preventive asthma therapy. J Pediatr. 2005;147(5):708.
39. Lemanske RF Jr, Mauger DT, Sorkness CA, et al. Step-up therapy for children with uncontrolled asthma receiving inhaled corticosteroids. N Engl J Med. 2010;362(11):975-985.
40. US Department of Health and Human Services (DHS); US Food and Drug Administration. FDA Drug Safety Communication: New Safety Requirements for Long-Acting Inhaled Asthma Medications Called Long-Acting Beta-Agonists (LABAs). Rockville, MD: MedWatch Online; Published February 18, 2010. http://www.fda.gov/Drugs/DrugSafety / PostmarketDrugSafetyInformationforPatientsandProviders/ucm200776.htm. Accessed May 12, 2011.
41. Kamps AW, Brand PL, Roorda RJ. Determinants of correct inhalation technique in children attending a hospital-based asthma clinic. Acta Paediatr. 2002;91(2):159-163. (Pubitemid 34252523)
42. Platts-Mills TA. The role of immunoglobulin E in allergy and asthma. Am J Respir Crit Care Med. 2001;164(8, pt 2):S1-S5.
43. Arbes SJ Jr, Gergen PJ, Vaughn B, Zeldin DC. Asthma cases attributable to atopy: results from the Third National Health and Nutrition Examination Survey. J Allergy Clin Immunol. 2007;120(5):1139-1145. (Pubitemid 350029902)
44. Casale TB, Martin RJ. Clinical importance of identifying immunoglobulin E-mediated disease in patients with asthma. Clin Cornerstone. 2009; 9(3):20-29.
45. Morgan WJ, Crain EF, Gruchalla RS, et al. Results of a home-based environmental intervention among urban children with asthma. N Engl J Med. 2004;351(11):1068-1080. (Pubitemid 39167511)
46. N agata M, Nakagome K. Allergen immunotherapy in asthma: current status and future perspectives. Allergol Int. 2010;59(1):15-19.
47. XOLAIR (omalizumab) [prescribing information]. South San Francisco, CA: Genentech, Inc. 2010. http://www.gene.com/gene/products/information /pdf/xolair-prescribing.pdf. Accessed May 12, 2011.